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Abstract
Objective
Thyroid cancer (TC) is one of the most common endocrine malignancies with a rapidly
increasing worldwide presence. In Pakistan, it is more prevalent in females than males and has
an incidence rate of 2.1%. Obesity and excess body mass index (BMI) has been linked to several
cancers and is thought to be a risk factor for TC. We aim to investigate the incidence of TC in
our population and understand it’s correlation with obesity.
Subjects
The study was a retrospective case series conducted in the years 2000 to 2014, at the Aga Khan
University Hospital (AKUH), Karachi, Pakistan where 156 patients who had been diagnosed and
treated for TC were analyzed. Clinicopathological data was collected from medical records of
these patients and weight and height were measured, pre-surgery, post-surgery, and at follow
up. The BMI was correlated with patient variables for any significant associations.
Results
The patient set comprised of 38.5% males and 61.5% females with a mean age of 47.77 (SD ±
14.35). The BMI was significantly associated with age as 72.8% of participants were obese and
>45 years old as compared to 27.2% who were under 45 years and obese (p-value <0.001). Upon
comparison of the pre-surgery, post-surgery, and current mean BMI, Bonferroni pairwise
comparisons showed no significant difference (p>0.999).
Conclusion 
The majority of-of TC patients among the Pakistani population were obese and female. Age was
significantly associated with the risk of having a higher BMI. Moreover, differences in BMI pre
and post-surgery could not be statistically proven.
Categories: Endocrinology/Diabetes/Metabolism, Genetics, Epidemiology/Public Health
Keywords: bmi, endocrinology, oncology
Introduction
Thyroid cancer (TC) is the most common endocrine malignancy and its incidence is increasing
dramatically all over the world since the last few decades [1]. In the United States, the incidence
has increased from 3.6 per 100,000 in 1973 to 8.7 per 100,000 in 2002 [2] and it has been ranked
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the 5th most common cancer in women with nearly 3% cancer diagnosis in 2010 (45,000 new
cases). In Pakistan, the incidence rate of TC is 2.1% among all malignancies and it was found to
be more prevalent among females with a female to male ratio of 2.6:1 [3] The reason for this
significant rise in incidence can be due to recent advanced screening techniques and early
detection rather than true increase in disease occurrence, but still the exact cause remains
controversial [4].
Thyroid cancer is a malignancy arising from an abnormal cell cycle of follicular or parafollicular
thyroid cells and it is categorized into differentiated TC (DTC) and undifferentiated TC. DTC
accounts for approximately 90% of all thyroid malignancies and consists of three different
histological subtypes: papillary (two-third cases), follicular (10%-20%), and medullary (5%-
10%) [5]. Undifferentiated TC i.e., anaplastic type accounts for less than 5% cases of all TC. In
Pakistan, among all variants of TC, papillary carcinoma was found to be the most common
(69%), followed by follicular carcinoma (11.6%), medullary carcinoma (6.9%), anaplastic
carcinoma (5.9%), non-Hodgkin’s lymphoma (2.9%), and unclassified tumours (0.9%) [3] and
this rate of occurrence is comparable to international data.
The sexual disparity in TC incidence suggests that there may be some hormonal and
reproductive factors responsible. Irregular menstrual cycle, miscarriages or abortions, multiple
pregnancies or live births, surgical menopause which includes hysterectomy and bilateral
oophorectomy and lactation suppressants were all associated with TC risk among women.
However, miscarriage or abortion, particularly in the first pregnancy, is the most established
contributing reproductive factor. The most common risk factor was found to be previous
exposure to ionizing radiations, benign thyroid conditions which carry the risk of becoming
malignant, and iodine deficiency [6]. Thyroid nodular disease is one of the well-established
independent risk factors for the development of TC and its incidence increases with increasing
weight (>60 kg) and increasing age, specifically in women [7].
According to many studies, environmental and genetic predispositions play a major role in TC
development. Furthermore, obesity is a growing health problem not only in developed
countries but all over the world. Obesity is precisely defined as body mass index (BMI) greater
than 30 kg/m2 and it carries an increased risk for many chronic illnesses such as hypertension,
diabetes, heart diseases, sleep apnoea, musculoskeletal diseases, and cancers at several organ
sites. It has been determined that about 20% of all cancer cases are due to excess bodyweight
[8].
Excess BMI has also been linked to aggressiveness of the tumor, severe presentation, and
higher risk of death as it has been shown by studies that obese patients tend to present with
more advanced stages of breast cancer [9], higher grade of prostate cancer with higher risk of
recurrence [10] and tumor size with higher overall mortality risk from all cancers combined.
Like other cancers, obesity moderately increases the aggressiveness of TC as well as the rate of
microscopic extra thyroidal invasion and advanced TNM stages, the majority presenting with
stage III and IV [11]. However, there have been other studies showing no relation of TC with
excess BMI. In a recent study conducted in China, it was found that the prevalence of thyroid
nodules in both the sexes with an overall detection rate of 42.6% with 40.0% and 46.5% among
men and women respectively, while TC was reported in 0.3% overall and 0.15% in men and
0.50% in women. The detection rate was directly related to increasing age, high systolic blood
pressure, lighter weight, and smaller height [12]. Similarly, another study conducted in San
Francisco also reported no association of TC with height, weight, and BMI [13].
As a result, it can be grasped that the relationship between BMI and TC is a controversial one,
as some studies have quoted positive relation, particularly in females, while others have not.
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Thus the aim of our study was to investigate the association of BMI and TC in the Pakistani
population with the hypothesis that increasing BMI can be a significant factor for thyroid
malignancies.
Materials And Methods
The study was of cross-sectional design in which a total of 221 patients who had been
diagnosed with and subsequently treated for TC (either complete thyroidectomy or partial
thyroidectomy) in the years 2001- 2014 at Aga Khan University Hospital (AKUH), Karachi,
Pakistan were identified and then further screened according to the inclusion/exclusion
criteria. The diagnosis was made on the basis of preoperative fine needle aspiration cytology
(FNAC) and was confirmed by postoperative frozen section biopsy of the specimen. An ethical
exemption was sought from the Ethical Review Committee of AKUH.
Out of the pool of 221 patients, a total of 156 patients were included in the study based on the
fact that they had provided informed consent, had complete clinicopathologic data, and known
follow up status. Similarly, patients were excluded if they lacked any of the above. Survival
status was defined as whether the patients were alive or dead at last contact (through the clinic
or follow up visit). For the calculation of BMI, the following formula was used:
BMI = body weight in kg/ height in m2 [14].
Body mass index or Quetelet index is a measure of the relative size of the body and it is defined
as body mass in kilograms (kg) divided by the square of height in meters (m2) [14]. The World
Health Organization (WHO) regards a BMI to be normal (18.5 to 25 kg/m2), underweight (<18.5
kg/m2), overweight (>25 kg/m2), obese (>30 kg/m2). In Asians, the cut-off values of overweight
and obesity are lower than the WHO criteria. Proposed classification of weight by BMI in adult
Asians is found to be underweight (<18.5), normal (18.5 to 22.9), overweight (>23), and obese
(>25) [15].
Statistical analysis
We performed the analysis using Statistical Package for the Social Sciences (SPSS), version 22.0
for Windows (SPSS Inc., Chicago, IL, US). Descriptive statistics were calculated for categorical
variables by computing their frequencies and were assessed using χ2 test. The distribution of
quantitative variables was computed by their means and standard deviations were reported
after checking for normality assumption and assessed using independent t-test. The pre and
post-BMI difference of each individual were considered by paired t-test and the difference in
pre, post, and current BMI of each individual was assessed by repeated measure analysis of
variance (ANOVA). Bonferroni pairwise comparison test was applied to assess the pairwise
difference. Cross-tabulation was run for each categorical variable to look for any zero cell count
or sparse data and such variables were grouped together in a meaningful way.
Results
The patient set comprised of 60 (38.5%) males and 96 (61.5%) females, making up a total of 156
patients with a mean age of 47.77 (SD ± 14.35). Out of these, the majority were above 45 years
of age (57.4%) and were obese (51.9%) (Table 1).
 Frequency (%)
Age division <45 years 66 (42.9)
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≥45 years 89 (57.1)
Gender
Male 60 (38.5)
Female 96 (61.5)
Preoperative BMI
Underweight 8 (5.13)
Normal weight 46 (29.5)
Overweight 21 (13.5)
Obese 81 (51.9)
Postoperative BMI
Underweight 10 (6.4)
Normal weight 39 (25)
Overweight 29 (18.6)
Obese 78 (50)
Current BMI
Underweight 10 (6.4)
Normal weight 31 (19.9)
Overweight 26 (16.7)
Obese 89 (57.1)
Type of tumour
Papillary 115 (73.7)
Medullary 16 (10.3)
Follicular 11 (7.1)
Anaplastic 5 (3.2)
Others 9 (5.8)
Type of surgery
Complete thyroidectomy 112 (71.8)
Partial thyroidectomy 35 (22.4)
Unknown 9 (5.8)
Survival status
Alive 147 (94.2)
Dead 9 (5.8)
TABLE 1: Patient characteristics (n=156)
BMI: body mass index.
Categorizing the patient set into groups above and below the age of 45 years revealed that the
majority of males were obese in both age groups. However, the larger part of females under 45
were of normal weight and obese over the age of 45. About 69% of females >45 years of age were
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obese versus 31% of women <45 years of age (Table 2).
Age BMI Gender n(%)
  Male Female
<45 years
Underweight 3 (12.50) 3 (7.10)
Normal weight 8(33.3) 18 (42.9)
Overweight 4(16.7) 8(19)
Obese 9(37.5) 13(31.0)
>45 years
Underweight 1(2.8) 1(1.9)
Normal weight 12(33.3) 8(15.10)
Overweight 1(2.8) 7(13.2)
Obese 22(61.1) 37 (69.80)
TABLE 2: Gender and age-specifc body mass index (BMI) values
Moreover, this distinction of age was significantly associated with a higher BMI as 72.8% of
participants were obese and >45 years old as compared to 27.2% who were under 45 years and
obese (p-value <0.001) (Table 3).
Age BMI n (%) P value
 Underweight Normal weight Overweight Obese
  <0.001<45 years 6 (75) 26(56.5) 12 (60) 22(27.20)
≥45 years 29(25) 20(43.5) 8(40) 59(72.8)
TABLE 3: Correlation of body mass index (BMI) with age
p-value calculated using chi-square test and considered significant at <0.05.
Upon comparison of pre-surgery, post-surgery, and current mean BMI (which was collected at
last follow up visit), Bonferroni pairwise comparisons showed no significant difference
(p>0.999) (Table 4). However, the difference in mean post and mean current BMI was
marginally significant (p=0.054). Furthermore, no mean BMI difference was observed between
the two genders in preoperative (p=0.59), postoperative (p=0.28), and current BMI (p=0.09).
2018 Ali et al. Cureus 10(3): e2364. DOI 10.7759/cureus.2364 5 of 9
BMI Preoperative BMI n(%) Postoperative BMI n(%) Current BMI n(%)
Underweight 8(5.13) 10(6.4) 10(6.4)
Normal weight 46(29.5) 39(25) 31(19.9)
Overweight 21(13.5) 29(18.6) 26(16.7)
Obese 81(51.9) 78(50) 89(57.1)
Mean BMI ± SD 25.28 ± 4.51 25.23 ± 4.58 26.11 ± 5.05
TABLE 4: Comparison of mean preoperative, postoperative, and current body mass
index (BMI)
Discussion
Several studies have shown links between increased BMI and high prevalence of TC in different
parts of the world [16-17]. The relation of obesity and risk of cancer has been studied
thoroughly as obesity is becoming a worldwide health challenge. The trends of increasing
obesity also impact the incidence, mortality, and morbidity rates of the majority of cancers. Our
study reflects the growing trend of obesity as the majority of patients enrolled were 45 years or
older and were also obese, having BMI >25.
Several studies have shown the association of excess BMI with the risk of cancer at several
organ sites including colon, breast (in postmenopausal women), endometrium, oesophagus,
and kidney [18]. In recent decades, the incidence rate of TC has risen dramatically along with a
significant rise in obesity rates [1]. But this relation is controversial because several studies
have suggested a positive relation of BMI with TC [11,19] while many studies have shown no
significant relation [20].
This study revealed that the majority of males suffering from TC were obese, whether under or
over the age of 45 years. In contrast, female patients of TC were mostly of normal weight if
under the age of 45 years, and overweight if they were above 45 years. Since women above the
age of 45 typically experience menopause, the association of menopause and TC has been a
topic of interest. A systematic review and meta-analysis conducted in 2015 concluded from the
data of 25 independent studies that common hormonal factors such as oral contraceptives and
hormone replacement therapy did not have an effect on TC risk. However, an older age at
menopause and parity were considered risk factors for TC, with a longer duration of breast
feeding providing a protective effect [21].
An important observation was that a higher age was significantly associated with an increased
BMI with a p-value of <0.001. A pooled analysis of 12 case-control studies showed a significant
association of BMI with TC risk in women (OR = 1.2), excluding males [22]. In a similar vein, a
case-control study revealed that excess weight (BMI > 25 kg/m2) increased individual
susceptibility to DTC. However, this augmented risk was evident in women but not in men [23].
Moreover, a meta-analysis of 141 prospective studies revealed that a 5 kg/m2 increase in BMI
was strongly associated with TC (relative risk = 1.14, 95% CI: 1.06–1.23) in both sexes [24]. In
another study comprising of a prospective cohort, it was suggested that BMI was not associated
with TC incidence.
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A comparison of the mean BMI of our patient set pre-surgery, post-surgery and upon follow up
indicated that there was no significant difference in patient’s BMI. A borderline significant
association was seen when the mean post-surgery and current BMI (on last follow up) were
compared. This effort to compare pre- and post- surgery BMI was in light of the frequent
observation that thyroidectomized patients commonly report weight gain which persists in
spite of weight loss efforts. A retrospective chart review of 120 patients done by Jonklaas et al.
did confirm that patients who had undergone thyroidectomy in the previous year, had weight
gain in the following year [25]. However, similar to our findings, Weinreb et al. found no
significant difference in weight gain as compared to a control group of euthyroid patients [26].
There are several possible mechanisms reported to explain the relation of TC with obesity.
These include insulin resistance (IR), insulin growth factor-1 (IGF-1), adipocytokines, thyroid
stimulating hormone (TSH), and estrogens [15]. IR possibly plays a major role as it is associated
with other risk factors including IGF-1, adipocytokines, and TSH in a true relationship with a
potential for development and/or progression of TC [27]. Increased BMI has also been
associated with higher serum TSH values which are shown to be an independent factor for TC.
DTCs express TSH receptors on their cell membranes. Higher levels of serum TSH are found to
be associated with increased cell proliferation and probably increased risk for mutations and
development of TC [28], which are likely to be mediated by TSH receptors [29].
TC occurs more commonly in women as compared to men [23]. This was supported by our study
in which the vast majority of patients were female at 61.5%. This gender prevalence can be due
to endogenous sex hormone i.e., estrogen. Adipose tissue plays a role in the synthesis and
conversion of sex steroids and this role becomes more prominent after menopause when the
function of ovaries ceases. Therefore postmenopausal obese women have higher levels of serum
estrogen than normal weight women. Estrogen receptors (ER) are expressed on DTC cell
lineages and may have modulatory effects on TC cells [30]. However, the preoperative and
postoperative mean BMI as investigated in this work, were not significantly different between
the two genders.
Several limitations of our study are considered. These include the use of only cases and not
controls, due to which the incidence of TC in Pakistan cannot be judged. Also, due to the lack of
critical information or consent, we could not include data of all TC patients treated at our
hospital. The duration of data collection was also long and certain lifestyle and dietary changes
in the subjects have occurred in this time period which our study does not specifically discuss.
As documented by Pellegriti et al. in a review of TC risk factors, diet, and lifestyle changes have
not been studied in much detail in terms of TC and existing studies have provided controversial
results [1].
However, no such information existed in the context of Pakistan before and we report that at a
single tertiary care centre these associations of BMI and TC exist and our findings can be
generalized to other tertiary care centres of Pakistan.
Conclusions
This study revealed the associations of TC and BMI in patients presenting to a tertiary care
centre in Pakistan. Moreover, TC patients mostly presented with BMI >25 and were categorized
as obese according to the WHO standards for Asian populations. Age was significantly
associated with the risk of having a higher BMI and all patients (irrespective of gender) above
the age of 45 years were obese in this study. Moreover, differences in BMI pre- and post-surgery
could not be statistically proven. Further molecular investigations and case-control studies
might explain the relationship of BMI and TC in more detail.
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